Stanford big data techno-optimist and internist Russ Altman shows us how the power of machine learning in drug development is helping us understand adverse medication effects.

Path: Start » Living with Aspergillosis » General interest » Tracking Adverse Medication Events and Drug:Drug Interactions

Latest News posts

News archive

This content has been archived. It may no longer be relevant